A potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)

dc.authoridAZKUR, DILEK/0000-0002-4396-9087
dc.authoridArdicli, Ozge/0000-0001-6077-0478
dc.contributor.authorArdicli, Ozge
dc.contributor.authorAzkur, Ahmet Kursat
dc.contributor.authorAzkur, Dilek
dc.date.accessioned2025-01-21T16:35:15Z
dc.date.available2025-01-21T16:35:15Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstract[Abstract No tAvailable]
dc.identifier.doi10.1111/all.15333
dc.identifier.endpage2567
dc.identifier.issn0105-4538
dc.identifier.issn1398-9995
dc.identifier.issue8
dc.identifier.pmid35491434
dc.identifier.scopus2-s2.0-85135598765
dc.identifier.scopusqualityQ1
dc.identifier.startpage2565
dc.identifier.urihttps://doi.org/10.1111/all.15333
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24101
dc.identifier.volume77
dc.identifier.wosWOS:000796432400001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofAllergy
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectadenoviral vectors; mucosal immunity; next-generation vaccine; SARS-CoV-2; trained innate immunity
dc.titleA potential immunological silver bullet for COVID-19: The trivalent chimpanzee adenoviral serotype-68 vector (Tri:ChAd)
dc.typeEditorial

Dosyalar